111,082 CME Group Inc. $CME Shares Sold by Robeco Institutional Asset Management B.V.

Robeco Institutional Asset Management B.V. decreased its stake in CME Group Inc. (NASDAQ:CME) by 62.6% in the third quarter, HoldingsChannel reports. The firm owned 66,317 shares of the financial services provider’s stock after selling 111,082 shares during the period. Robeco Institutional Asset Management B.V.’s holdings in CME Group were worth $17,374,000 at the end of the most recent quarter.

A number of other institutional investors have also recently bought and sold shares of CME. BlackRock Inc. purchased a new stake in CME Group during the second quarter valued at about $6,749,965,000. Bank of New York Mellon Corp acquired a new position in shares of CME Group in the second quarter worth about $867,313,000. Alphabet Inc. acquired a new position in shares of CME Group in the second quarter worth about $769,376,000. Mitsubishi UFJ Asset Management Co. Ltd. acquired a new position in shares of CME Group in the second quarter worth about $629,771,000. Finally, Bank of America Corp DE purchased a new position in shares of CME Group in the second quarter worth approximately $622,679,000. Hedge funds and other institutional investors own 87.75% of the company’s stock.

Key CME Group News

Here are the key news stories impacting CME Group this week:

• Positive Sentiment: Record quarterly results: CME reported third-quarter revenue of approximately $1.74 billion, up 10.6% year over year and above the $1.71 billion consensus estimate. EPS of $3.02 also exceeded expectations of $2.99, while average daily volume reached a record 29.4 million contracts. CME third-quarter revenue article
• Positive Sentiment: Crypto derivatives momentum: CME recorded approximately $469.5 billion in crypto derivatives volume during the third quarter, highlighting growing demand for regulated digital-asset products. The company has not separately disclosed crypto revenue, so the direct earnings contribution remains unclear. CME crypto derivatives volume article
• Positive Sentiment: More bullish analyst coverage: JPMorgan upgraded CME from “underweight” to “overweight” and set a $367 price target, citing improving volume and earnings prospects. Wells Fargo also raised its target to $333. JPMorgan CME rating
• Positive Sentiment: Expansion opportunities: CME plans to launch CME Securities Clearing on December 7, potentially broadening its clearing business. Management also highlighted strong participation and international volume growth. CME Securities Clearing article
• Neutral Sentiment: Valuation remains debated: UBS lifted its price target from $270 to $310 but retained a “neutral” rating, indicating that much of the improved outlook may already be reflected in the stock. UBS CME rating
• Negative Sentiment: Insider sale: Director Martin Gepsman sold 400 shares for approximately $121,000. The transaction reduced his holdings by 1.56%, but he still owns 25,244 shares, limiting the sale’s significance. CME director stock sale

Wall Street Analysts Forecast Growth

A number of equities research analysts have recently issued reports on CME shares. TD Cowen boosted their price target on shares of CME Group from $292.00 to $300.00 and gave the company a “buy” rating in a report on Monday, October 5th. Wall Street Zen upgraded shares of CME Group from a “strong sell” rating to a “sell” rating in a research report on Saturday, October 3rd. Bank of America raised their price objective on shares of CME Group from $226.00 to $230.00 and gave the stock an “underperform” rating in a research note on Thursday, July 23rd. UBS Group raised their price objective on shares of CME Group from $270.00 to $310.00 and gave the stock a “neutral” rating in a research note on Thursday. Finally, The Goldman Sachs Group lowered their price objective on shares of CME Group from $267.00 to $245.00 and set a “sell” rating on the stock in a research report on Tuesday, June 30th. Ten analysts have rated the stock with a Buy rating, six have assigned a Hold rating and two have assigned a Sell rating to the stock. According to MarketBeat, the stock has a consensus rating of “Hold” and an average target price of $313.29.

Insider Activity at CME Group

In related news, Director Elizabeth Cook sold 500 shares of the firm’s stock in a transaction that occurred on Monday, September 14th. The shares were sold at an average price of $280.11, for a total transaction of $140,055.00. Following the completion of the sale, the director directly owned 17,916 shares in the company, valued at approximately $5,018,450.76. This trade represents a 2.72% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, Director William Shepard acquired 293 shares of the stock in a transaction that occurred on Friday, September 25th. The shares were bought at an average cost of $268.76 per share, for a total transaction of $78,746.68. Following the completion of the transaction, the director directly owned 263,289 shares of the company’s stock, valued at $70,761,551.64. This represents a 0.11% increase in their position. Additional details regarding this purchase are available in the official SEC disclosure. Insiders sold 15,900 shares of company stock valued at $4,377,655 over the last ninety days. 0.30% of the stock is owned by company insiders.

CME Group Stock Down 0.1%

NASDAQ:CME opened at $305.71 on Friday. The business’s fifty day moving average price is $277.60 and its 200 day moving average price is $270.74. The firm has a market capitalization of $109.93 billion, a price-to-earnings ratio of 25.08, a PEG ratio of 3.92 and a beta of 0.24. The company has a current ratio of 1.02, a quick ratio of 1.02 and a debt-to-equity ratio of 0.13. CME Group Inc. has a 1-year low of $218.31 and a 1-year high of $329.16.

CME Group (NASDAQ:CME) last announced its quarterly earnings data on Wednesday, October 21st. The financial services provider reported $3.02 EPS for the quarter, topping analysts’ consensus estimates of $2.99 by $0.03. CME Group had a return on equity of 16.23% and a net margin of 63.33%. The firm had revenue of $1.74 billion during the quarter, compared to analyst estimates of $1.71 billion. During the same period last year, the company posted $2.68 EPS. The business’s quarterly revenue was up 10.6% compared to the same quarter last year. On average, sell-side analysts forecast that CME Group Inc. will post 12.36 earnings per share for the current fiscal year.

CME Group Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Friday, September 25th. Stockholders of record on Wednesday, September 9th were issued a $1.30 dividend. The ex-dividend date was Wednesday, September 9th. This represents a $5.20 dividend on an annualized basis and a dividend yield of 1.7%. CME Group’s dividend payout ratio is currently 42.66%.

CME Group Company Profile

CME Group Inc operates global derivatives marketplaces that provide trading, clearing and settlement services for futures and options contracts. Its products cover major asset classes, including interest rates, equity indexes, foreign currencies, agricultural commodities, energy and metals. The company also provides market data, benchmark information and related services used by financial institutions, corporations, producers, investors and other market participants.

CME Group’s exchange portfolio includes CME, the Chicago Board of Trade, the New York Mercantile Exchange and COMEX.